Lngresos Netos Cambio Fecha
Agenus USD 39.17M 49.8M 2026-03
AstraZeneca USD 2.51B 573M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Celldex Therapeutics USD -73.5M 5.18M 2026-06
Eisai JPY 18.24B 21.49B 2026-06
Merck USD -1.34B 2.9B 2026-06
Northwest Biotherapeutics USD -3.4M 23.78M 2026-03
Pfizer USD -248M 2.94B 2026-06
Plus Therapeutics USD -6.95M 1.23M 2026-03
Roche Holding CHF 6.87B 1.4B 2026-06